Possible Drug Target Identified for Cystic Fibrosis


An age-dependent increase in ceramide levels in the lungs of mice with cystic fibrosis causes many of the symptoms of the disease, which can be reversed by an inhibitor that normalizes ceramide levels, according to research published online March 30 in Nature Medicine.

Related Videos
Meghan Harrison, DO & Brittany Perry, DO
Steven Selbst, MD
Susan J. Kressly, MD, FAAP
Earls and Flower
Related Content
© 2023 MJH Life Sciences

All rights reserved.